or Try an Advanced Search...

    Technical Analysis for COGT - Cogent Biosciences, Inc.

    Grade Last Price % Change Price Change
    F 9.80 -0.10% -0.01
    COGT closed down 0.1 percent on Thursday, September 28, 2023, on 44 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical COGT trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Low Weakness -0.10%
    Wide Bands Range Expansion -0.10%
    Oversold Stochastic Weakness -0.10%
    New 52 Week Closing Low Bearish 1.14%
    Slingshot Bearish Bearish Swing Setup 1.14%
    Older End-of-Day Signals for COGT ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    60 Minute Opening Range Breakout about 9 hours ago
    Possible NR7 about 11 hours ago
    Possible Inside Day about 11 hours ago
    60 Minute Opening Range Breakdown about 14 hours ago
    Down 2 % about 14 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    COGT Chart by TradingView
    Basic chart:

    Profile

    Cogent Biosciences, Inc. is a biotechnology company focused on developing precision therapies for genetically defined diseases. Cogent's most advanced program, PLX9486, is a highly selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Cogent is headquartered in Cambridge, MA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Clinical Medicine Disease Gastrointestinal Enzymes Protein Kinase Inhibitor Tyrosine Kinase Mastocytosis Systemic Mastocytosis Gastrointestinal Stromal Tumor Imatinib Advanced Gastrointestinal Stromal Tumors Gastrointestinal Stromal Tumors

    Is COGT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Aug 15 Cogent Biosciences Is Beginning To Differentiate Its KIT Inhibitor
    Aug 13 After losing 15% in the past year, Cogent Biosciences, Inc. (NASDAQ:COGT) institutional owners must be relieved by the recent gain
    Aug 8 Cogent Biosciences GAAP EPS of -$0.59
    Aug 8 Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2023 Financial Results
    Jul 10 Analysts Say These 2 Stocks Are Their ‘Top Picks’ for the Rest of 2023
    Jun 14 $10M Bet On GameStop? Check Out These 3 Stocks Insiders Are Buying
    Jun 12 9 Analysts Have This to Say About Cogent Biosciences
    Jun 9 Cogent Biosciences Announces Closing of Upsized Public Offering of Common Stock
    Jun 7 Cogent Biosciences Announces Participation in the Jefferies Healthcare Conference
    Jun 7 Cogent Biosciences down 7% on pricing $150M offering
    See more COGT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 15.68
    52 Week Low 9.48
    Average Volume 746,869
    200-Day Moving Average 12.01
    50-Day Moving Average 11.78
    20-Day Moving Average 11.26
    10-Day Moving Average 10.27
    Average True Range 0.51
    RSI (14) 30.07
    ADX 31.63
    +DI 10.30
    -DI 33.88
    Chandelier Exit (Long, 3 ATRs) 11.71
    Chandelier Exit (Short, 3 ATRs) 11.00
    Upper Bollinger Bands 13.51
    Lower Bollinger Band 9.02
    Percent B (%b) 0.17
    BandWidth 39.82
    MACD Line -0.64
    MACD Signal Line -0.46
    MACD Histogram -0.1759
    Fundamentals Value
    Market Cap 190.19 Million
    Num Shares 19.4 Million
    EPS
    Price-to-Sales 3.49
    Price-to-Book 6.51
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 10.18
    Resistance 3 (R3) 10.13 9.97 10.11
    Resistance 2 (R2) 9.97 9.87 9.99 10.09
    Resistance 1 (R1) 9.88 9.81 9.93 9.93 10.07
    Pivot Point 9.72 9.72 9.74 9.74 9.72
    Support 1 (S1) 9.63 9.62 9.68 9.68 9.53
    Support 2 (S2) 9.47 9.56 9.49 9.51
    Support 3 (S3) 9.38 9.47 9.49
    Support 4 (S4) 9.43